Literature DB >> 6315733

Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.

R D Sekura, F Fish, C R Manclark, B Meade, Y L Zhang.   

Abstract

Pertussis toxin, the major toxin produced by Bordetella pertussis, catalyzes the ADP-ribosylation of a specific membrane polypeptide which appears to be involved in regulation of the catalytic subunit of adenylate cyclase. In the current study, a rapid purification procedure has been developed for the preparation of pertussis toxin in high yields. Through the sequential use of the affinity matrices Affi-Gel blue and fetuin-Sepharose 4B, milligram quantities of apparently homogeneous toxin can be prepared from the culture supernatants of B. pertussis strain 165. Structural, amino acid, and immunologic analyses indicate that toxin prepared from strain 165 is indistinguishable from toxin prepared from other strains. Activation of the ADP-ribosyltransferase activity requires treatment of the toxin with a thiol reducing agent. This activation appears to be associated with the reduction of intrachain disulfide bonds present in the catalytic subunit. Activated toxin preparations catalyzed ADP-ribosylation of a protein (Mr = 40,000) present in cell membrane preparations obtained from human red blood cells and platelets, rat adipocytes, and cyc- S49 cells which are deficient in the adenylate cyclase regulatory component which is the substrate for cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315733

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  88 in total

1.  Homologous beta-adrenergic desensitization in isolated rat hepatocytes.

Authors:  J A García-Sáinz; B Michel
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

2.  Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.

Authors:  Atsuko Kodama; Kazunari Kamachi; Yoshinobu Horiuchi; Toshifumi Konda; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

3.  Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli.

Authors:  W N Burnette; J L Arciniega; V L Mar; D L Burns
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.

Authors:  T M Finn; R Shahin; J J Mekalanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Characterization of serological responses to pertussis.

Authors:  Mineo Watanabe; Beverly Connelly; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2006-03

6.  Purification and characterization of the heat-labile toxin of Bordetella pertussis.

Authors:  Y L Zhang; R D Sekura
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose.

Authors:  G D Armstrong; M S Peppler
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

8.  Promoter of the pertussis toxin operon and production of pertussis toxin.

Authors:  A Nicosia; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland.

Authors:  J Mertsola
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

10.  Identification of B-cell epitopes on the S4 subunit of pertussis toxin.

Authors:  P H Ibsen; A Holm; J W Petersen; C E Olsen; I Heron
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.